Mc Guire Investment Group, LLC Recursion Pharmaceuticals, Inc. Transaction History
Mc Guire Investment Group, LLC
- $729 Million
- Q2 2025
A detailed history of Mc Guire Investment Group, LLC transactions in Recursion Pharmaceuticals, Inc. stock. As of the latest transaction made, Mc Guire Investment Group, LLC holds 18,500 shares of RXRX stock, worth $102,119. This represents 0.01% of its overall portfolio holdings.
Number of Shares
18,500
Previous 23,500
21.28%
Holding current value
$102,119
Previous $124,000
25.0%
% of portfolio
0.01%
Previous 0.02%
Shares
2 transactions
Others Institutions Holding RXRX
# of Institutions
365Shares Held
286MCall Options Held
3.28MPut Options Held
3.16M-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl34.8MShares$192 Million1.99% of portfolio
-
Vanguard Group Inc Valley Forge, PA32.3MShares$178 Million0.0% of portfolio
-
Baillie Gifford & CO24.4MShares$135 Million0.12% of portfolio
-
Black Rock Inc. New York, NY17.3MShares$95.6 Million0.0% of portfolio
-
Softbank Group Corp Minato Ku Tokyo, M014.7MShares$81 Million0.27% of portfolio
About RECURSION PHARMACEUTICALS, INC.
- Ticker RXRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 180,480,000
- Market Cap $996M
- Description
- Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. The company develops REC-994, which is in Phase IIa clinical trial to treat cerebral cav...